Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 34, 2009, Pages 14478-14483

  Cheung, Arthur Kwok Leung ^a   Lung, Hong Lok ^b   Ko, Josephine Mun Yee ^b   Cheng, Yue ^a,c   Stanbridge, Eric J ^d   Zabarovsky, Eugene R ^e   Nicholls, John M ^b   Chua, Daniel ^b   Tsao, Sai Wah ^b   Guan, Xin Yuan ^b   Lung, Maria Li ^b  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cell cycle arrest; Microcell mediated chromosome transfer; MIPOL1; Promoter hypermethylation

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; MEMBRANE PROTEIN; MIRROR IMAGE POLYDACTYLY 1; PROTEIN; SLC25A21 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL NUCLEUS; CHROMOSOME 14; CHROMOSOME ANALYSIS; CHROMOSOME SUBSTITUTION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE LOSS; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; CELL CYCLE; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 14; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA METHYLATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, EXPERIMENTAL; POLYMERASE CHAIN REACTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

MUS;

EID: 70149086514     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900198106     Document Type: Article

References (40)

1. Lo KW, et al. (2000) High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 60(13):3348-3353.
2. Shao J, et al. (2002) High frequency loss of heterozygosity on the long arms of chromosomes 13and14 in nasopharyngeal carcinoma in Southern China. Chinese Medical Journal 115(4):571-575. (Pubitemid 34538105)
3. Mutirangura A, Pornthanakasem W, Sriuranpong V, Supiyaphun P, Voravud N (1998) Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int J Cancer 78(2):153-156. (Pubitemid 28443169)
4. Yoshimoto T, et al. (2007) High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J Pathol 213(4):392-401. (Pubitemid 350206511)
5. Hu J, et al. (2002) High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours. Br J Cancer 87(2):218-224. (Pubitemid 34886347)
6. Hoshi M, et al. (2000) Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss. Br J Cancer 82(11):1801-1807. (Pubitemid 30307392)
7. Ihara Y, et al. (2002) Allelic imbalance of 14q32 in esophageal carcinoma. Cancer Genet Cytogenet 135(2):177-181. (Pubitemid 34786770)
8. Mourra N, et al. (2007) High frequency of chromosome 14 deletion in early-onset colon cancer. Dis Colon Rectum 50(11):1881-1886. (Pubitemid 350077105)
9. Simon M, et al. (1995) Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression. Cancer Res 55(20):4696-4701.
10. Tepel M, et al. (2008) Frequent promoter hypermethylation and transcriptional down-regulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int J Cancer 123(9):2080-2086.
11. Felsberg J, et al. (2006) DNA methylation and allelic losses on chromosome arm 14q in oligodendroglial tumours. Neuropathol Appl Neurobiol 32(5):517-524. (Pubitemid 44401513)
12. El-Rifai W, Sarlomo-Rikala M, Andersson LC, Miettinen M, Knuutila S (2000) High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci. Genes Chromosomes Cancer 27(4):387-391. (Pubitemid 30127627)
13. Chang WY, Cairns P, Schoenberg MP, Polascik TJ, Sidransky D (1995) Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55(15):3246-3249.
14. Bandera CA, et al. (1997) Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res 57(3):513-515.
15. O'Connell P, et al. (1999) Loss of heterozygosity at D14S62 and metastatic potential of breast cancer. Journal of the National Cancer Institute 91(16):1391-1397. (Pubitemid 29399997)
16. Pehlivan D, et al. (2008) Loss of heterozygosity at chromosome 14q is associated with poor prognosis in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 134(12):1267-1276.
17. Robertson GP, Hufford A, Lugo TG (1997) A panel of transferable fragments of human chromosome 11q. Cytogenet Cell Genet 79(1-2):53-59. (Pubitemid 28107816)
18. Kondoh S, et al. (2002)Anovel gene is disrupted at a 14q13 breakpoint of t(2;14) in a patient with mirror-image polydactyly of hands and feet. Journal of Human Genetics 47(3):136-139. (Pubitemid 34292847)
19. Kamnasaran D, et al. (2003) Rearrangement in the PITX2 and MIPOL1 genes in a patient with a t(4;14) chromosome. European Journal of Human Genetics 11(4):315-324. (Pubitemid 36553490)
20. Maher CA, et al. (2009) Transcriptome sequencing to detect gene fusions in cancer. Nature 458(7234):97-101.
21. Protopopov AI, et al. (2002) Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. The Journal of Gene Medicine 4(4):397-406.
22. Ko JM, et al. (2008) Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. Molecular Cancer Research 6(4):592-603.
23. Cheng Y, et al. (2000) A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer 28(1):82-91. (Pubitemid 30176766)
24. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ (1998) The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396(6707):177-180. (Pubitemid 28523620)
25. Tang B, et al. (1998) Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 4(7):802-807. (Pubitemid 28331021)
26. Roy S, etal. (2008) Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle (Georgetown, Texas) 7(12):1828-1835.
27. Hwang CF, et al. (2003) Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. Cancer Lett (Shannon, Irel.) 189(2):231-236.
28. Baba Y, et al. (2001) Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detection and Prevention 25(5):414-419.
29. Cheng Y, et al. (1998) Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 95(6):3042-3047. (Pubitemid 28135851)
30. Cheng Y, et al. (2003) Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 37(4):359-368. (Pubitemid 36775778)
31. Lung HL, et al. (2006) TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 66(19):9385-9392. (Pubitemid 44623634)
32. Zhang H, et al. (2004) Sequential cytogenetic and molecular cytogenetic characterization of an SV40T-immortalized nasopharyngeal cell line transformed by Epstein-Barr virus latent membrane protein-1 gene. Cancer Genet Cytogenet 150(2):144-152. (Pubitemid 38456856)
33. Lung HL, et al. (2008) Characterization of a novel epigenetically- silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 123(2):401-408.
34. Lung HL, et al. (2008) Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. Int J Cancer 122(6):1288-1296.
35. Ko JM, et al. (2005) Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 43(3):284-293.
36. Cheung AK, et al. (2008) Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Res 68(19):8137-8145.
37. Cheng Y, et al. (2002) Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabaseregion of chromosome band 11q13.Genes Chromosomes Cancer 34(1):97-103. (Pubitemid 34260601)
38. Leung AC, et al. (2008) Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Int J Cancer 122(3):587-594.
39. Nicholls JM, et al. (2006) Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med 3(2):e27.
40. Lung HL, et al. (2004) Fine mapping of the 11q22-23 tumor-suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 112(4):628-635.